Changeflow GovPing Pharma & Drug Safety TAQ DNA POLYMERASE MUTANT Patent Publication
Routine Notice Added Final

TAQ DNA POLYMERASE MUTANT Patent Publication

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2026030656A1 concerning a TAQ DNA POLYMERASE MUTANT. The publication date is March 18, 2026. The inventors have not yet filed their designation.

What changed

This document is a patent publication from the European Patent Office (EPO) for a "TAQ DNA POLYMERASE MUTANT," identified by publication number EP2026030656A1, with a publication date of March 18, 2026. The International Patent Classification (IPC) codes associated with this publication include C12N 9/12, C12N 9/96, and C12P 19/34. The designated states cover a broad range of European countries.

As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, companies involved in biotechnology, pharmaceutical research, or DNA polymerase applications should be aware of this publication for potential intellectual property considerations and competitive landscape analysis. No specific actions are required from a compliance perspective, and no penalties are associated with this notice.

Source document (simplified)

← EPO Patent Bulletin

TAQ DNA POLYMERASE MUTANT

Publication EP2026030656A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12N 9/12 20060101AFI20260208BHEP C12N 9/96 20060101ALI20260208BHEP C12P 19/34 20060101ALI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030656A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Patent Filing
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Intellectual Property Biotechnology

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.